Roche's new Erivedge wins nod in U.K.; Teva, Perrigo roll out copy of Merck's Temodar;

@FiercePharma: Still trending: Pharma professionals feeling angst, but see a few rays of hope. Story | Follow @FiercePharma

@EricPFierce: India's Aurobindo puts sterile injectables unit into a subsidiary to unlock value. Wonder if it will shop it next? Story | Follow @EricPFierce

@CarlyHFierce: Sanofi's statement on the latest bribery allegations in China: Statement | Follow @CarlyHFierce

> Roche's ($RHHBY) new skin cancer drug Erivedge won clearance in the U.K., following conditional approval by European regulators last month. Report

> Teva Pharmaceutical Industries ($TEVA) and Perrigo ($PRGO) have teamed up to launch a generic version of Merck's ($MRK) cancer drug Temodar. Report

> Federal officials are probing the use of antipsychotic drugs on children covered by Medicaid, worried that the powerful treatments are prescribed unnecessarily. Report (sub. req.)

> India's Biocon said it has launched a new treatment for psoriasis, priced at about $130 per vial, or 50% less than rival drugs made by Big Pharma. Report

> Indian officials have given drugmakers 30 more days to re-price the drugs newly added to the list of heavily discounted essential medicines. Report

Medical Device News

@FierceMedDev: Kona snags ex-SonoSite exec to helm renal denervation. Article | Follow @FierceMedDev

@DamianFierce: Medtronic is spending $200M on a telehealth outfit with an eye on slashing healthcare costs. News | Follow @DamianFierce

@MichaelGFierce: New antivirus system could protect medical devices from infection. Article | Follow @MichaelGFierce

> Agilent, SomaLogic team up on Dx technology. Item

> Montreal's EMcision launches catheters for pancreatic cancer. More

Biotech News

@FierceBiotech: Icon signs up to boost Taiwan's stake in drug development. FierceCRO article | Release | Follow @FierceBiotech

@JohnCFierce: If Roche does try to buy Alexion, the company is going to get slaughtered by the analysts. More | Follow @JohnCFierce

@RyanMFierce: CollabRx elbows into software game for gene interpretation. FierceBiotech IT story | Follow @RyanMFierce

@EmilyMFierce: Newly discovered proteins could play role in destroying cancer cells. More from FierceBiotech Research | Follow @EmilyMFierce

> Biotechs crowd list of top growth leaders as Big Pharmas shrink staffs. Feature

> Which are the most efficient drug developers in biopharma? More

> Vical discards melanoma immunotherapy Allovectin after PhIII failure. Report

CRO News

> Covance offers service to keep contracts under control. Item

> ScinoPharm, Sundia team up in China. Report

> Parexel bets big on the future as revenue swells. Story

> AMRI swings to red despite another sales jump. More

> InVentiv takes aim at blockbusters with biosimilar deal. Article

Biotech IT News

> Medidata to score $287.5M in major financing. News

> CollabRx elbows into software game for gene interpretation. More

> Roche rolls out updated software for next-generation sequencing. Report

> Big Data analysis outfit GNS teams with Inova on predicting preterm birth. Story

> Gene by Gene acquires software upstart Arpeggi. Article

And Finally... New muscle-building drugs in development could be the next big thing in sports doping, experts say. Report

Suggested Articles

After a slow start, Teva's Ajovy launch is improving following the FDA approval for an autoinjector.

After Trump's "Buy American" executive order for essential medicines, the pharma industry is pushing back.

The U.S. is slamming the brakes on its $765 million loan to Kodak amid insider trading allegations and questions about its fitness for the job.